ซัพพลายเออร์ที่มีใบอนุญาตการทำธุรกิจ
ซัพพลายเออร์ที่ผ่านการตรวจสอบแล้ว
Fenofibrate is a drug of the fibrate class. It is mainly used to reduce cholesterol levels in patients at risk of cardiovascular disease. Like other fibrates,it reduces both lowdensity lipoprotein (LDL) and very low density lipoprotein (VLDL) levels,as well as increasing highdensity lipoprotein (HDL) levels and reducing triglycerides level. It is used alone or along with statins in the treatment of hypercholesterolemia and hypertriglyceridemia.
1. Fenofibrate has significant clinical efficacy in the treatment of lipid abnormalities in diabetic patients.
2. Fenofibrate has the effect of regulating blood lipid.
3. Fenofibrate has anti-inflammatory and lowers fibrinogen levels.
4. Fenofibrate has preventive neuroprotective effects.
Fenofibrate is mainly used for primary hypercholesterolemia or mixed dyslipidemia. Fenofibrate appears to decrease the risk of cardiovascular disease and possibly diabetic retinopathy in those with diabetes mellitus, and firstly indicated for the reduction in the progression of diabetic retinopathy in patients with type 2 diabetes and existing diabetic retinopathy in Australia. It also appears to be helpful in decreasing amputations of the lower legs in this same group of people. Fenofibrate also has an off-label use as an added therapy of high blood uric acid levels in people who have gout.
ซัพพลายเออร์ที่มีใบอนุญาตการทำธุรกิจ
ซัพพลายเออร์ที่ผ่านการตรวจสอบแล้ว 
